documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

209 rows where agency_id = "FDA" and posted_year = 1999 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 1

  • 1999 · 209 ✖

agency_id 1

  • FDA · 209 ✖
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1976-S-0001-0001 FDA Methods for Conducting Recall Effectiveness Checks - OPEN FDA-1976-S-0001 Methods for Conducting Recall Effectiveness Checks Other Recommendations 1999-12-30T05:00:00Z 1999 12     2018-03-16T18:14:29Z   0 0 090000648051b0d1
FDA-1995-S-0039-0156 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1999-12-28T05:00:00Z 1999 12 2009-01-02T05:00:00Z   2016-09-30T14:23:06Z   0 0 090000648055c3f6
FDA-1999-D-0009-0002 FDA Disclosure of Materials Provided to Advisory Committees FDA-1999-D-0009 Draft Guidance for Industry on Disclosing Information Provided to Advisory Committees in Connection With Open Advisory Committee Meetings Related to the Testing or Approval of New Drugs and Convened by the Center for Drug Evaluation and Research, Beginning on January 1, 2000; Availability Notice Notice of Availability 1999-12-23T05:00:00Z 1999 12 1999-12-23T05:00:00Z 2000-02-23T04:59:59Z 2014-07-16T13:42:06Z   0 0 09000064804a59d0
FDA-1996-N-0006-0002 FDA Eligibility Criteria for Considering Additional Conditions in the Over-the-Counter Drug Monograph System FDA-1996-N-0006 Notice of Proposed Rule re Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded Proposed Rule Notice of Proposed Rulemaking (NPRM) 1999-12-20T05:00:00Z 1999 12 1999-12-20T05:00:00Z 2000-03-23T04:59:59Z 2015-05-05T15:10:01Z   0 0 09000064804f9934
FDA-1998-D-0021-0002 FDA Industry on ANDA's: Impurities in Drug Substances FDA-1998-D-0021 FDA Notice NAD-Notice of Availability of Data 1999-12-15T05:00:00Z 1999 12     2008-05-16T21:18:01Z   0 0 09000064805640ba
FDA-1999-M-0037-0001 FDA PMA Medtronic Interstim System for Urinary Control FDA-1999-M-0037 Medical Devices; Availability of Safety and Effectiveness Summaries for PMA Notice Notice of Data Availability 1999-12-09T05:00:00Z 1999 12     2025-07-30T19:27:54Z 98-2263 0 0 09000064804a5d72
FDA-1980-N-0074-0068 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 HFD-560 , Warner Lambert, Consumer Healthcare Prod., CTFA, FDC Reports Other MM-Memorandum of Meeting 1999-12-08T05:00:00Z 1999 12     2008-05-30T22:52:47Z   0 0 09000064805bb4ba
FDA-1999-P-0059-0001 FDA Reg/Guide to Label Medical Devices contain'g Phthalate Plasticizers-CLOSED FDA-1999-P-0059 FDA/CDRH to Sanford J Lewis Other LET-Letter 1999-12-07T05:00:00Z 1999 12     2008-04-25T00:13:57Z   0 0 09000064804a66c0
FDA-1999-N-0052-0001 FDA Actions That Can be Requested by Petition; Denials, Withdraw FDA-1999-N-0052 FDA Notice NPR-Notice of Proposed Rule-Making 1999-12-03T05:00:00Z 1999 12 1999-12-03T05:00:00Z 2000-02-29T04:59:59Z 2008-04-25T00:14:43Z   0 0 09000064804a6148
FDA-1999-D-0009-0001 FDA Disclosure of Materials Provided to Advisory Committees FDA-1999-D-0009 Guidance for Industry on the Disclosure of Materials Provided to Advisory Committees in Connection with Open Advisory Committee Meetings Convened by the Center for Drug Evaluation and Research Beginning on January 1, 2000; Availability Notice Notice of Availability 1999-12-02T05:00:00Z 1999 12 1999-12-02T05:00:00Z 2000-02-29T04:59:59Z 2014-07-17T01:05:09Z   0 0 09000064804a59ca
FDA-1991-N-0043-0012 FDA Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement FDA-1991-N-0043 FDA Notice N-Notice 1999-12-02T05:00:00Z 1999 12     2008-05-16T23:40:56Z   0 0 090000648052af1a
FDA-1991-N-0033-0011 FDA Fatty Acids & Heart Disease, Hlth.Claims & Label Statements FDA-1991-N-0033 FDA Notice N-Notice 1999-12-02T05:00:00Z 1999 12     2008-05-16T23:40:25Z   0 0 0900006480529612
FDA-1991-N-0043-0011 FDA Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement FDA-1991-N-0043 FDA Notice N-Notice 1999-12-02T05:00:00Z 1999 12     2008-05-16T23:40:54Z   0 0 090000648052af16
FDA-1991-N-0033-0012 FDA Fatty Acids & Heart Disease, Hlth.Claims & Label Statements FDA-1991-N-0033 FDA Notice N-Notice 1999-12-02T05:00:00Z 1999 12     2008-05-16T23:40:19Z   0 0 0900006480529614
FDA-2020-D-1958-0001 FDA FDA-2020-D-1958 Guidance for Industry: Seafood HACCP Transition Guidance Other Guidance 1999-12-01T05:00:00Z 1999 12 2020-09-21T04:00:00Z   2024-11-12T23:24:59Z   1 0 0900006484869392
FDA-1999-D-3543-0001 FDA Seafood HACCP transition guidance FDA-1999-D-3543 Guidance for Industry: Seafood HACCP Transition Guidance Other Guidance 1999-12-01T05:00:00Z 1999 12 2020-09-30T04:00:00Z   2024-11-12T23:26:15Z   1 0 09000064848a586c
FDA-1998-N-0026-0003 FDA Mercury Compounds in Drugs and Food FDA-1998-N-0026 FDA Notice NAD-Notice of Availability of Data 1999-11-30T05:00:00Z 1999 11     2008-05-16T21:28:55Z   0 0 0900006480564966
FDA-1998-N-0026-0004 FDA Mercury Compounds in Drugs and Food FDA-1998-N-0026 FDA Notice NAD-Notice of Availability of Data 1999-11-30T05:00:00Z 1999 11     2008-05-16T21:28:55Z   0 0 0900006480564969
FDA-1997-N-0060-0002 FDA Feed mill license in accord with Animal Drug Avalblty Act FDA-1997-N-0060 Animal Drug Availability Act; Medicated Feed Mill Licenses Notice Notice of Final Rule 1999-11-24T00:00:00Z 1999 11 1999-11-19T05:00:00Z   2025-05-15T16:25:41Z 99-29856 0 0 09000064805d0304
FDA-1994-P-0041-0002 FDA Require Labeling of Trans Fatty Acid & Prohibit Deceptive Claims-CLOSED FDA-1994-P-0041 Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims; Pages 1-100 Proposed Rule NPR-Notice of Proposed Rule-Making 1999-11-17T05:00:00Z 1999 11 1999-11-17T05:00:00Z 2000-02-16T04:59:59Z 2010-02-12T19:30:22Z   0 0 09000064804fe332
FDA-1994-P-0041-0001 FDA Require Labeling of Trans Fatty Acid & Prohibit Deceptive Claims-CLOSED FDA-1994-P-0041 Food Labeling: Trans Fatty Acids in Nutrition Labeling, Nutrient Content Claims, and Health Claims; Pages 101-148 Proposed Rule NPR-Notice of Proposed Rule-Making 1999-11-17T05:00:00Z 1999 11 1999-11-17T05:00:00Z 2000-02-16T04:59:59Z 2010-02-12T19:28:39Z   0 0 09000064804fda73
FDA-1999-P-0127-0001 FDA ANDA for Sterile Cefuroxime Sodium, USP FDA-1999-P-0127 FDA/DMB to Quinn Consulting Services Other ACK-Acknowledgement Letter 1999-11-09T05:00:00Z 1999 11     2008-04-25T00:18:38Z   0 0 09000064804aea0a
FDA-1978-N-0018-0437 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA/CDER to The Procter & Gamble Company Other Letter(s) 1999-11-08T05:00:00Z 1999 11     2019-07-26T12:27:36Z   0 0 090000648055a6a5
FDA-1999-D-0081-0001 FDA Testing for Replication Competent Retrovirus in Retroviral FDA-1999-D-0081 Draft "Guidance for Industry: Supplemental Guidance on Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-up of Patients in Clinical Trials Using Retroviral Vectors;" Availability Notice Notice of Data Availability 1999-11-03T05:00:00Z 1999 11 1999-11-03T05:00:00Z 2000-02-02T04:59:59Z 2025-07-01T20:17:52Z 99-28560 0 0 09000064804a694a
FDA-1999-P-0108-0001 FDA Reclassify Fiber Optic Light Sources FDA-1999-P-0108 Notice - Gastroenterology-Urology Devices; Denial of Request for Change in Classification of Fiber Optic Light Sources Notice ND-Notice of Denial 1999-11-03T00:00:00Z 1999 11 1999-11-03T05:00:00Z   2025-05-16T19:01:53Z   0 0 09000064804ae5e8
FDA-1995-S-0039-0155 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1999-11-02T05:00:00Z 1999 11 2009-01-02T05:00:00Z   2016-09-30T14:23:06Z   0 0 090000648055c3f2
FDA-1996-P-0246-0022 FDA Establishes RACCs for Various Types of Food Products Candies FDA-1996-P-0246 Interim Response Letter from FDA CFSAN to Brach and Brock Confections, Hershey Foods Corporation Other Letter(s) 1999-11-01T05:00:00Z 1999 11 2014-02-20T05:00:00Z   2014-02-20T14:23:41Z   0 0 0900006480503988
FDA-1984-F-0029-0001 FDA SAFE USE OF POLYSORBATE AS AN EMULSIFIER FDA-1984-F-0029 FDA Notice NFR-Notice of Final Rule 1999-10-29T04:00:00Z 1999 10 1999-10-29T04:00:00Z 1999-11-30T04:59:59Z 2008-05-30T22:52:31Z   0 0 09000064805a81d9
FDA-1999-D-0110-0003 FDA Guidance for Medical Gloves A Workshop Manual FDA-1999-D-0110 Medical Gloves; Draft Guidance Manual; Availability; Extension of Comment Period Notice Extension of Comment Period 1999-10-29T04:00:00Z 1999 10 1999-10-29T04:00:00Z 2000-01-28T04:59:59Z 2025-06-17T16:32:54Z 99-28110 0 0 09000064804ae620
FDA-1999-D-0066-0001 FDA Sampling & Microbial Testing of Spent Irrigation Water FDA-1999-D-0066 Guidance for Industry: Reducing Microbial Food Safety Hazards for Sprouted Seeds and Guidance for Industry: Sampling and Microbial Testing of Spent Irrigation Water During Sprout Production Notice Notice of Data Availability 1999-10-28T04:00:00Z 1999 10 1999-10-28T04:00:00Z 1999-12-14T04:59:59Z 2025-07-19T09:00:20Z 99-28016 0 0 09000064804a67c8
FDA-1996-P-0309-0022 FDA Amend 101.12(b) Table 2 on Hard Candies FDA-1996-P-0309 Interim Response Letter from FDA/CFSAN to Brach and Brock Confections, Hershey Foods Corporation, and Nestle USA, Inc., King and Spalding Other Letter(s) 1999-10-26T04:00:00Z 1999 10 2014-02-20T05:00:00Z   2014-02-20T12:40:54Z   0 0 0900006480504ca1
FDA-1999-P-0126-0004 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/DMB to Pharmacia & Upjohn Inc. Other CR-Correction 1999-10-26T04:00:00Z 1999 10     2008-04-25T00:19:51Z   0 0 09000064804ae9ee
FDA-1999-P-0126-0003 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/DMB to Pharmacia & Upjohn Other ACK-Acknowledgement Letter 1999-10-26T04:00:00Z 1999 10     2008-04-25T00:19:51Z   0 0 09000064804ae9ed
FDA-1999-N-0099-0001 FDA Biotechnology in the Year 2000 & Beyond; Public Meetings FDA-1999-N-0099 FDA Notice NM-Notice of Meeting 1999-10-25T04:00:00Z 1999 10 1999-10-25T04:00:00Z 2000-01-14T04:59:59Z 2009-10-13T15:28:32Z   0 0 09000064804a6b42
FDA-1999-N-0035-0001 FDA Proposal to Debar Jay Marcus FDA-1999-N-0035 Jay Marcus; Proposal to Debar; Opportunity for a Hearing Notice Notice of Opportunity of Hearing 1999-10-21T04:00:00Z 1999 10     2024-10-22T17:56:31Z 99–26938 0 0 09000064804a5d45
FDA-1998-N-0041-0004 FDA Elimination of establishment license/product license FDA-1998-N-0041 Biological Products Regulated Under Section 351 of the Public Health Services Act; implementation of Biologics License; Elimination of Establishment License and Product License Notice Notice of Final Rule 1999-10-20T04:00:00Z 1999 10     2026-01-30T03:40:40Z 99-27159 0 0 090000648056e5ae
FDA-1999-N-0067-0005 FDA Regulations Under the Federal Import Milk Act FDA-1999-N-0067 Agency Information Collection Activities; Announcement of OMB Approval; Regulations Under the Federal Import Milk Act Notice Notice of Approval 1999-10-13T04:00:00Z 1999 10     2024-10-10T15:05:25Z 99-26223 0 0 09000064804a683e
FDA-1995-S-0039-0158 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1999-10-13T04:00:00Z 1999 10 2009-01-02T05:00:00Z   2016-09-30T14:23:07Z   0 0 090000648055c3fa
FDA-1999-D-0011-0001 FDA Chemistry,Mfging/Control Changes to an approved NADA/ANADA FDA-1999-D-0011 Guidance for Industry: Chemistry, Manufacturing and Control Changes to an Approved NADA or ANADA; Availability Notice Notice of Data Availability 1999-10-08T04:00:00Z 1999 10 1999-10-08T04:00:00Z 1999-12-16T04:59:59Z 2025-06-04T09:00:09Z 99-25492 0 0 09000064804a59fd
FDA-1999-D-0065-0003 FDA Reviewers on Evaluation of Human Pregnancy Outcome Data FDA-1999-D-0065 Advisory Committee for Reproductive Health Drugs; Notice of Meeting Notice Meeting 1999-10-04T04:00:00Z 1999 10     2025-06-03T15:46:14Z 99-25228 0 0 09000064804a67be
FDA-1997-N-0057-0001 FDA Human Cellular and Tissue-Based Products FDA-1997-N-0057 Suitability Determination for Donors of Human Cellular and Tissue-Based Products - Notice of Proposed Rule Notice NPR-Notice of Proposed Rule-Making 1999-10-01T04:00:00Z 1999 10 1999-09-30T04:00:00Z 1999-12-30T04:59:59Z 2010-10-06T21:13:49Z   0 0 09000064805cfd41
FDA-1995-S-0039-0154 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report (outside of agency unless indicated) 1999-09-28T04:00:00Z 1999 9 2009-01-02T05:00:00Z   2016-09-30T14:23:06Z   0 0 090000648055c3ef
FDA-1998-P-0084-0003 FDA ANDA for omeprazole delayed-release tablets-CLOSED FDA-1998-P-0084 Citizen Petition Denial from FDA CDER to AndrxPharmaceuticals, Inc. Other Denial of Petition 1999-09-23T04:00:00Z 1999 9     2024-07-17T16:04:00Z   0 0 0900006480584d87
FDA-1999-N-0031-0002 FDA Positron Emmission Tomography Drug Products FDA-1999-N-0031 Current Good Manufacturing Practices for Positron Emission Tomography Drug Products; Preliminary Draft Regulations; Availability Notice Notice of Data Availability 1999-09-23T04:00:00Z 1999 9 1999-09-22T04:00:00Z 1999-10-14T03:59:59Z 2025-03-19T19:39:19Z 02-7728 0 0 09000064804a5ce7
FDA-1999-N-0031-0001 FDA Positron Emmission Tomography Drug Products FDA-1999-N-0031 Current Good Manufacturing Practice for Positron Emission Tomography Drug Products; Preliminary Draft Proposed Rule; Availability Notice Notice of Data Availability 1999-09-23T04:00:00Z 1999 9 2002-04-01T05:00:00Z 2002-06-06T03:59:59Z 2025-03-19T19:31:46Z 02-7728 0 0 09000064804a5ce4
FDA-1998-P-0018-0002 FDA Drug products containing oxycodone hydrocloride tablet suitable-CLOSED FDA-1998-P-0018 Citizen Petition Approval from FDA CDER to King & Spalding Other Approval 1999-09-23T04:00:00Z 1999 9     2024-07-12T16:29:21Z   0 0 0900006480563c50
FDA-1980-N-0074-0067 FDA Anticaries Drug Products for OTC Human Use; FDA-1980-N-0074 FDA/CDER to Kleinfeld, Kaplan and Becker Other PDN-Petition Denial 1999-09-14T04:00:00Z 1999 9     2008-05-30T22:53:22Z   0 0 09000064805bb4a5
FDA-1999-P-0126-0002 FDA Abbreviated new drug application/topical dematological drug-CLOSED FDA-1999-P-0126 FDA/CDER to Glaxo Wellcome Inc Other LET-Letter 1999-09-14T04:00:00Z 1999 9     2008-04-25T00:19:51Z   0 0 09000064804ae9eb
FDA-1991-N-0033-0010 FDA Fatty Acids & Heart Disease, Hlth.Claims & Label Statements FDA-1991-N-0033 FDA Notice N-Notice 1999-09-09T04:00:00Z 1999 9 1999-09-09T04:00:00Z 1999-11-23T04:59:59Z 2008-05-16T23:40:20Z   0 0 0900006480529457
FDA-1998-N-0010-0001 FDA Program Priorities/Center for Food Safety & Applied Nutrition FDA-1998-N-0010 FDA Notice N-Notice 1999-09-09T04:00:00Z 1999 9 1999-09-09T04:00:00Z 1999-10-01T03:59:59Z 2008-05-16T21:28:44Z   0 0 09000064805590b0
FDA-1991-N-0043-0010 FDA Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement FDA-1991-N-0043 FDA Notice N-Notice 1999-09-09T04:00:00Z 1999 9 1999-09-09T04:00:00Z 1999-11-23T04:59:59Z 2008-05-16T23:40:47Z   0 0 090000648052aeb8
FDA-1991-N-0043-0009 FDA Antioxidant Vitamins & Cancer,Hlth. Claims & Label Statement FDA-1991-N-0043 FDA Notice N-Notice 1999-09-09T04:00:00Z 1999 9 1999-09-09T04:00:00Z 1999-11-23T04:59:59Z 2008-05-16T23:40:56Z   0 0 090000648052aeb5
FDA-1991-N-0033-0009 FDA Fatty Acids & Heart Disease, Hlth.Claims & Label Statements FDA-1991-N-0033 FDA Notice N-Notice 1999-09-09T04:00:00Z 1999 9 1999-09-09T04:00:00Z 1999-11-23T04:59:59Z 2008-05-16T23:40:29Z   0 0 0900006480529456
FDA-1996-N-0028-0008 FDA Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements FDA-1996-N-0028 Dietary Supplements; Center for Food Safety and Applied Nutrition (Small Business Outreach CGMPs in the Dietary Supplement Industry); Public Meeting Held September 28 and October 21, 1999), 9/3/1999 - Annoucement of Public Meeting Notice NM-Notice of Meeting 1999-09-08T04:00:00Z 1999 9 1999-09-08T04:00:00Z 1999-11-22T04:59:59Z 2009-09-24T04:50:05Z   0 0 09000064804fb8ac
FDA-1998-D-0098-0003 FDA Stability Testing of Drug Substances and Drug Products FDA-1998-D-0098 FDA Notice NM-Notice of Meeting 1999-08-26T04:00:00Z 1999 8     2008-05-16T21:23:18Z   0 0 0900006480586e5b
FDA-1999-N-0134-0002 FDA Public Health Impact of Foodborne Listeria Monocytogenes FDA-1999-N-0134 FDA Notice NM-Notice of Meeting 1999-08-24T04:00:00Z 1999 8 1999-08-24T04:00:00Z 1999-10-26T03:59:59Z 2008-04-25T00:16:54Z   0 0 09000064804aeb87
FDA-1999-N-0113-0007 FDA Vibrio Parahaemolyticus in molluscan shellfish public health FDA-1999-N-0113 FDA Notice NM-Notice of Meeting 1999-08-24T04:00:00Z 1999 8 1999-08-24T04:00:00Z 1999-10-26T03:59:59Z 2008-04-25T00:17:45Z   0 0 09000064804ae6aa
FDA-1999-N-0113-0006 FDA Vibrio Parahaemolyticus in molluscan shellfish public health FDA-1999-N-0113 FDA Notice NM-Notice of Meeting 1999-08-24T04:00:00Z 1999 8 1999-08-24T04:00:00Z 1999-10-26T03:59:59Z 2008-04-25T00:17:45Z   0 0 09000064804ae6a9
FDA-1999-H-0144-0001 FDA Civil Money Penalty; Walgreen Co. d/b/a Walgreen Drug Store #2139 FDA-1999-H-0144 HHS/FDA/CDER Administrative Compliant for Civil Penalties - Notice of Opportunity of Hearing Notice NPH-Notice of Opportunity of Hearing 1999-08-19T04:00:00Z 1999 8     2009-07-13T22:58:04Z   0 0 09000064804aef18
FDA-1999-F-0118-0002 FDA Filing of Food Additive Petition for Sucralose FDA-1999-F-0118 Food Additives Permitted for Direct Addition to Food for Human Consumption; Sucralose Notice Notice of Final Rule 1999-08-18T04:00:00Z 1999 8 1999-08-12T04:00:00Z 1999-09-14T03:59:59Z 2025-04-16T14:57:22Z 99 20888 0 0 09000064804ae93f
FDA-1999-N-0067-0004 FDA Regulations Under the Federal Import Milk Act FDA-1999-N-0067 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Regulations Under the Federal Import Milk Act; Correction Notice Correction 1999-08-18T04:00:00Z 1999 8     2024-10-10T15:02:38Z 99-20793 0 0 09000064804a683c
FDA-1999-F-0021-0001 FDA Irradiation in the Production, Processing & Handling of Food FDA-1999-F-0021 Notice of Filing of Food Additive Petition (FAP 9M4673), Caudill Seed Co., Inc. Notice NFL-Notice of Filing 1999-08-16T04:00:00Z 1999 8     2011-07-20T15:47:39Z   0 0 09000064804a5ac3
FDA-1999-P-0125-0001 FDA Refuse Abbreviated New Drug Applications for Gabapentin Tablets FDA-1999-P-0125 Acknowledgement Letter from FDA DMB to Palmer & Dodge, LLP Other Acknowledgement Letter/Receipt 1999-08-13T00:00:00Z 1999 8     2025-05-23T00:01:41Z   0 0 09000064804ae9c2
FDA-1999-D-0032-0001 FDA Quality Systems Regulation Information for Various Premarket FDA-1999-D-0032 Medical Devices; Final Guidance on Quality Systems Regulation Information for Various Premarket Submissions; Availability Notice Notice of Data Availability 1999-08-11T04:00:00Z 1999 8     2025-06-11T17:04:45Z 03-2375 0 0 09000064804a5d15
FDA-1999-D-0128-0001 FDA Cooperative Manufacturing Arrangements for Licensed FDA-1999-D-0128 Draft Guidance for Industry: Cooperative Manufacturing Arrangements for Licensed Biologics”; Availability Notice NAD-Notice of Availability of Data 1999-08-11T04:00:00Z 1999 8 1999-08-11T04:00:00Z 1999-10-05T03:59:59Z 2025-08-06T09:00:11Z   0 0 09000064804aea26
FDA-1998-N-0068-0009 FDA Regs for In Vivo Radiopharm used for Diagnosis & Monitoring FDA-1998-N-0068 HFA-250 Notice NAL-Notice of Approval 1999-08-11T04:00:00Z 1999 8     2008-05-16T21:31:26Z   0 0 0900006480571d55
FDA-1991-F-0012-0002 FDA Safe Use of Sucrose Acetate Isobutyrate As A Stabilizer FDA-1991-F-0012 FDA Notice NCR-Notice of Correction 1999-08-10T04:00:00Z 1999 8     2008-05-16T23:37:55Z   0 0 0900006480525eed
FDA-1999-N-0137-0003 FDA Infant Formula Recall Regulations, Information Collection FDA-1999-N-0137 Agency Information Collection Activities; Announcement of OMB Approval; Infant Formula Recall Regulations Notice Notice of Approval 1999-08-09T04:00:00Z 1999 8     2024-10-07T20:14:41Z 99-20258 0 0 09000064804aedc9
FDA-1985-N-0022-0010 FDA Drug Price Competition & Patent Term Restoration ACT 1984 FDA-1985-N-0022 Notice of Proposed Rulemaking re Drug Price Competition & Patent Term Restoration ACT 1984 Proposed Rule Notice of Proposed Rulemaking (NPRM) 1999-08-09T04:00:00Z 1999 8 1999-08-09T04:00:00Z 1999-11-05T04:59:59Z 2016-02-26T19:20:20Z   0 0 09000064805b3c13
FDA-1999-N-0115-0001 FDA Reporting of Use Errors With Medical Devices FDA-1999-N-0115 Global Harmonization Task Force; Draft Document on Proposal for Reporting of Use Errors with Medical Devices; Availability Notice Notice of Data Availability 1999-08-09T04:00:00Z 1999 8 1999-08-05T04:00:00Z 1999-09-08T03:59:59Z 2024-10-16T20:18:24Z 99-20140 0 0 09000064804ae8f8
FDA-1999-N-0137-0004 FDA Infant Formula Recall Regulations, Information Collection FDA-1999-N-0137 Agency Information Collection Activities; Announcement of OMB Approval; Infant Formula Recall Regulations Notice Notice of Approval 1999-08-09T04:00:00Z 1999 8     2024-10-08T12:28:45Z 99-20258 0 0 09000064804aedcb
FDA-1999-F-0120-0001 FDA Listed Gum or Wood Rosin Derivatives FDA-1999-F-0120 Hercules, Inc.; Filing of Food Additive Petition Notice Notice of Filing 1999-08-09T00:00:00Z 1999 8     2025-05-02T17:57:26Z 99-20090 0 0 09000064804ae95c
FDA-1999-D-0110-0001 FDA Guidance for Medical Gloves A Workshop Manual FDA-1999-D-0110 Medical Gloves; Draft Guidance Manual; Availability Notice Notice of Data Availability 1999-08-05T04:00:00Z 1999 8 1999-08-05T04:00:00Z 1999-10-03T03:59:59Z 2025-06-18T09:00:04Z 99-19192 0 0 09000064804ae60c
FDA-1999-N-0141-0004 FDA Supplements and Other Changes to an Approved Application FDA-1999-N-0141 FDA Notice NM-Notice of Meeting 1999-08-05T04:00:00Z 1999 8     2008-04-25T00:20:16Z   0 0 09000064804aee50
FDA-1999-N-0141-0003 FDA Supplements and Other Changes to an Approved Application FDA-1999-N-0141 FDA Notice NM-Notice of Meeting 1999-08-05T04:00:00Z 1999 8     2008-04-25T00:20:16Z   0 0 09000064804aee4f
FDA-1999-D-0110-0002 FDA Guidance for Medical Gloves A Workshop Manual FDA-1999-D-0110 Medical Gloves; Draft Guidance Manual; Availability Notice Notice of Data Availability 1999-08-05T04:00:00Z 1999 8 1999-08-05T04:00:00Z 1999-10-03T03:59:59Z 2025-06-17T15:55:32Z 99-19192 0 0 09000064804ae61c
FDA-1999-D-0049-0001 FDA Draft Guidance for Ind - Changes to an Approved NDA or ANDA FDA-1999-D-0049 Changes to an Approved NDA or ANDA; Proposed Rule and Draft Companion Guidance; Public Meeting Notice NM-Notice of Meeting 1999-08-05T00:00:00Z 1999 8     2025-05-21T22:37:52Z   0 0 09000064804a6017
FDA-1978-N-0018-0436 FDA Sunscreen Drug Products -OPEN FDA-1978-N-0018 Letter from FDA/CDER to The Cosmetic, Toiletry & Fragrance Association Other Letter(s) 1999-08-03T04:00:00Z 1999 8     2019-07-25T18:01:31Z   0 0 090000648055a696
FDA-1999-N-0067-0003 FDA Regulations Under the Federal Import Milk Act FDA-1999-N-0067 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Regulations Under the Federal Import Milk Act; Correction Notice Correction 1999-08-03T04:00:00Z 1999 8     2024-10-10T15:00:30Z 99-19688 0 0 09000064804a683b
FDA-1999-N-0067-0002 FDA Regulations Under the Federal Import Milk Act FDA-1999-N-0067 Agency Information Collection Activities; Submission for 0MB Review; Comment Request; Regulations Under the Federal Import Milk Act Notice 30 Day Proposed Information Collection 1999-07-27T04:00:00Z 1999 7 1999-07-26T04:00:00Z 1999-08-26T03:59:59Z 2025-03-18T13:56:04Z 99-18927 0 0 09000064804a683a
FDA-1999-N-0095-0003 FDA Procedures for Statements on Dietary Supplements FDA-1999-N-0095 Agency Information Collection Activities; Announcement of OMB Approval; Food Labeling: Notification Procedures for Statements on Dietary Supplements Notice Notice of Approval 1999-07-22T04:00:00Z 1999 7     2024-11-19T13:34:09Z 99-18694 0 0 09000064804a6ae4
FDA-1999-N-0015-0001 FDA Topical Antifungal Drug Products FDA-1999-N-0015 Topical Antifungal Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph Notice NPR-Notice of Proposed Rule-Making 1999-07-22T04:00:00Z 1999 7 1999-07-22T04:00:00Z 1999-10-21T03:59:59Z 2024-10-16T15:56:13Z 99-18699 0 0 09000064804a5a6f
FDA-1999-N-0016-0002 FDA Premarket Notification for a New Dietary Ingredient FDA-1999-N-0016 Agency Information Collection Activities; Announcement of OMB Approval; Premarket Notification for a New Dietary Ingredient Notice Notice of Approval 1999-07-22T04:00:00Z 1999 7     2025-03-18T11:52:30Z 99-18696 0 0 09000064804a5a80
FDA-1997-D-0009-0003 FDA Use of IEC 60601 Standards; Medical Electrical; FDA-1997-D-0009 FDA Notice NAD-Notice of Availability of Data 1999-07-15T04:00:00Z 1999 7     2008-05-16T21:59:17Z   0 0 09000064805c9a38
FDA-1999-P-0043-0001 FDA Suitability Petition Propoxyphene Napsylate/Acetaminophen 100mg/325mg as ANDA-CLOSED FDA-1999-P-0043 Acknowledgment Letter from FDA DDM to Mikart Inc. Other Acknowledgement Letter/Receipt 1999-07-09T04:00:00Z 1999 7     2017-04-26T18:14:14Z   0 0 09000064804a5f3d
FDA-1999-N-0096-0002 FDA Labeling Requirements for Color Additives and Petitions FDA-1999-N-0096 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Labeling Requirements for Color Additives (Other Than Hair Dyes) and Petitions Notice 30 Day Proposed Information Collection 1999-07-08T04:00:00Z 1999 7 1999-07-08T04:00:00Z 1999-08-10T03:59:59Z 2024-11-19T19:44:29Z 99-17242 0 0 09000064804a6af0
FDA-1999-N-0013-0002 FDA Extralabel Drug Use in Animals;Agency Information Collection FDA-1999-N-0013 Agency Information Collection Activities; Submission for OMB Review; Comment Request; Extralabel Drug Use in Animals Notice 30 Day Proposed Information Collection 1999-07-02T04:00:00Z 1999 7 1999-06-30T04:00:00Z 1999-07-31T03:59:59Z 2024-11-19T17:02:35Z 99-16593 0 0 09000064804a5a4d
FDA-1999-N-0141-0001 FDA Supplements and Other Changes to an Approved Application FDA-1999-N-0141 FDA Notice NPR-Notice of Proposed Rule-Making 1999-06-30T04:00:00Z 1999 6 1999-06-30T04:00:00Z 1999-09-14T03:59:59Z 2008-04-25T00:20:16Z   0 0 09000064804aee46
FDA-1999-N-0141-0002 FDA Supplements and Other Changes to an Approved Application FDA-1999-N-0141 FDA Notice NPR-Notice of Proposed Rule-Making 1999-06-30T04:00:00Z 1999 6 1999-06-30T04:00:00Z 1999-09-14T03:59:59Z 2008-04-25T00:20:16Z   0 0 09000064804aee49
FDA-1999-D-0050-0001 FDA Bioavilability & Bioequivalence Studies for Nasal Aerosols FDA-1999-D-0050 Draft Guidance for Industry on Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action; Availability Notice Notice of Data Availability 1999-06-25T04:00:00Z 1999 6 1999-06-25T04:00:00Z 1999-09-23T03:59:59Z 2025-06-05T09:00:08Z 99-16140 0 0 09000064804a6066
FDA-1996-N-0028-0007 FDA Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Dietary Supplements FDA-1996-N-0028 Dietary Supplements; Center for Food Safety and Applied Nutrition (Small Business Outreach); Public Meeting Held July 12, 1999, 6/18/1999 Notice NM-Notice of Meeting 1999-06-23T04:00:00Z 1999 6 1999-06-23T04:00:00Z 1999-08-13T03:59:59Z 2009-10-09T03:24:35Z   0 0 09000064804fb89f
FDA-1999-N-0051-0003 FDA Development of Strategy for Dietary Supplements FDA-1999-N-0051 FDA Notice NM-Notice of Meeting 1999-06-23T04:00:00Z 1999 6 1999-06-23T04:00:00Z 1999-08-13T03:59:59Z 2008-04-25T00:14:28Z   0 0 09000064804a60e6
FDA-1999-N-0051-0002 FDA Development of Strategy for Dietary Supplements FDA-1999-N-0051 FDA Notice NCR-Notice of Correction 1999-06-17T04:00:00Z 1999 6     2008-04-25T00:14:27Z   0 0 09000064804a60d3
FDA-1999-N-0007-0001 FDA Proposed Classification of Female Condoms FDA-1999-N-0007 Obstetrical and Gynecological Devices; Proposed Classification of Female Condoms Proposed Rule Notice of Proposed Rulemaking (NPRM) 1999-06-16T04:00:00Z 1999 6 1999-06-10T04:00:00Z 1999-09-09T03:59:59Z 2024-10-10T19:38:34Z 99-14653 0 0 09000064804a59a9
FDA-1999-D-0010-0001 FDA In Vivo Pharmacokinetics & Bioavail Levothyroxine Sodium Tab FDA-1999-D-0010 Draft Guidance for Industry on in Vivo Pharmacokinetics and Bioavailability Studies and in Vitro Dissolution Testing for Levothyroxine Sodium Tablets; Availability Notice Notice of Data Availability 1999-06-15T00:00:00Z 1999 6 1999-06-15T00:00:00Z 1999-08-10T03:59:59Z 2025-05-28T09:01:12Z 99-14751 0 0 09000064804a59e3
FDA-1999-P-0079-0001 FDA Reclassify Constrained Hip Prosthesis Metal/Polymer FDA-1999-P-0079 FDA/DMB to Orthopedic Surgical Manufacturers Association Other ACK-Acknowledgement Letter 1999-06-14T04:00:00Z 1999 6     2008-04-25T00:00:57Z   0 0 09000064804a6902
FDA-1995-S-0039-0140 FDA 75-Day Premarket Notifications for New Dietary Ingredients FDA-1995-S-0039 Report from FDA/CFSAN Other RPT-Report 1999-06-11T04:00:00Z 1999 6 2008-12-03T05:00:00Z   2016-09-30T14:23:00Z   0 0 090000648055c3ba
FDA-1999-D-0065-0002 FDA Reviewers on Evaluation of Human Pregnancy Outcome Data FDA-1999-D-0065 Reviewer Guidance Evaluation of Human Pregnancy Outcome Data Supporting & Related Material Guidance 1999-06-10T04:00:00Z 1999 6     2025-06-03T15:02:38Z   0 0 09000064804a67b9
FDA-1999-D-0065-0001 FDA Reviewers on Evaluation of Human Pregnancy Outcome Data FDA-1999-D-0065 Draft Guidance for Reviewers on Evaluation of Human Pregnancy Outcome Data; Availability Notice Notice of Data Availability 1999-06-10T04:00:00Z 1999 6 1999-06-10T04:00:00Z 1999-09-03T03:59:59Z 2025-06-04T09:00:09Z 99-14149 0 0 09000064804a67b8
FDA-1991-F-0012-0001 FDA Safe Use of Sucrose Acetate Isobutyrate As A Stabilizer FDA-1991-F-0012 FDA Notice NFR-Notice of Final Rule 1999-06-10T04:00:00Z 1999 6 1999-06-10T04:00:00Z 1999-07-07T03:59:59Z 2008-05-16T23:37:55Z   0 0 0900006480525e47

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);